Mathias Kleinert

Q: What is Mathias Kleinert email address?

Email Mathias Kleinert at makl181@yahoo.de and mathias.kleinert@boehringer-ingelheim.com. This email is the most updated Mathias Kleinert's email found in 2026.

Q: How to contact Mathias Kleinert?

To contact Mathias Kleinert send an email to makl181@yahoo.de or mathias.kleinert@boehringer-ingelheim.com. (updated on February 24, 2025)

Senior Manager Pricing, Access, and Payer Strategy - TA Oncology at Boehringer Ingelheim | Frankfurt Rhine-Main Metropolitan Area

About Mathias Kleinert

Mathias Kleinert currently serves as Senior Manager for Pricing, Access, and Payer Strategy in the Therapeutic Area Oncology at Boehringer Ingelheim, where he plays a pivotal role in shaping the company’s global market access strategies for innovative oncology treatments. With a deep expertise in health economics, pharmacoeconomics, and pricing strategy, Mathias is dedicated to ensuring that breakthrough medicines reach patients efficiently while delivering sustainable value to healthcare systems. His work involves developing comprehensive access solutions that align with evolving payer requirements, reimbursement landscapes, and regulatory frameworks across diverse markets.

Mathias’s key projects include leading the strategic planning and execution of pricing models for priority assets within the oncology pipeline, optimizing market access pathways, and collaborating closely with cross-functional teams to support successful product launches. His focus on value-based healthcare and health economics enables him to craft compelling value propositions that resonate with payers and healthcare providers alike. Additionally, Mathias leverages his expertise in sales effectiveness and business strategy to facilitate market penetration and ensure the commercial success of Boehringer Ingelheim’s oncology portfolio.

With a passion for patient-centric solutions, Mathias strives to design access strategies that not only maximize commercial potential but also uphold the core mission of providing patients with timely access to innovative therapies. His leadership in global pricing and access initiatives underscores his commitment to balancing commercial objectives with the imperative of delivering meaningful health outcomes, making him a key driver in the company’s efforts to advance oncology care worldwide.

Mathias Kleinert Work